
MERCK & CO., INC.
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | PSNL | 14.04M | $91.57M |
![]() | ALEC | 3.55M | $10.50M |
![]() | STRO | 2.72M | $2.37M |
![]() | MRNA | 2.31M | $59.62M |
![]() | XLO | 1.48M | $1.25M |
![]() | CARM | 1.47M | $403.67K |
![]() | LVTX | 1.15M | $1.79M |
![]() | KYMR | 772K | $43.70M |
![]() | VRDN | 93K | $2.02M |
![]() | HURA | 14K | $34.60K |

Personalis, Inc.
PSNL
Shares Held
14.04M
Value
$91.57M

Alector, Inc.
ALEC
Shares Held
3.55M
Value
$10.50M

Sutro Biopharma, Inc.
STRO
Shares Held
2.72M
Value
$2.37M

Moderna, Inc.
MRNA
Shares Held
2.31M
Value
$59.62M

Xilio Therapeutics, Inc.
XLO
Shares Held
1.48M
Value
$1.25M

Carisma Therapeutics, Inc.
CARM
Shares Held
1.47M
Value
$403.67K

LAVA Therapeutics N.V.
LVTX
Shares Held
1.15M
Value
$1.79M

Kymera Therapeutics, Inc.
KYMR
Shares Held
772K
Value
$43.70M

Viridian Therapeutics, Inc.
VRDN
Shares Held
93K
Value
$2.02M

TuHURA Biosciences, Inc.
HURA
Shares Held
14K
Value
$34.60K
